ID | 110761 |
Author |
Manabe, Kazuyoshi
Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
Nishioka, Yasuhiko
Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Kishi, Jun
Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
KAKEN Search Researchers
Inayama, Mami
Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
Aono, Yoshinori
Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
KAKEN Search Researchers
Nakamura, Yoichi
Clinical Research Center for Allergy and Rheumatology, National Kochi Hospital
Ogushi, Fumitaka
Clinical Research Center for Allergy and Rheumatology, National Kochi Hospital
Bando, Hiroyasu
Department of Pulmonary Medicine, Tokushima Prefectural Central Hospital
Tani, Kenji
Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
KAKEN Search Researchers
Sone, Saburo
Department of Internal Medicine and Molecular Therapeutics, Institute of Health Biosciences, The University of Tokushima Graduate School
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | bronchoalveolar lavage fluid
macrophage-derived chemokine
thymus-and activation-regulated chemokine
eosinophilic pneumonia
alveolar macrophages
interstitial lung diseases
|
Content Type |
Journal Article
|
Description | Macrophage-derived chemokine (MDC/CCL22) and thymus-and activation-regulated chemokine (TARC/CCL17) are ligands for CC chemokine receptor 4. Recently, TARC has been reported to play a role in the pathogenesis of idiopathic eosinophilic pneumonia (IEP). The purpose of this study was to evaluate the role of MDC in IEP and other interstitial lung diseases (ILDs). MDC and TARC in the bronchoalveolar lavage fluid (BALF) were measured by enzymelinked immunosorbent assay in patients with ILDs and healthy volunteers (HV). We also examined the expression of MDC mRNA in alveolar macrophages (AM) by real-time quantitative reverse transcriptase-polymerase chain reaction. Both MDC and TARC were detected only in BALF obtained from IEP patients. The concentration of MDC was higher than that of TARC in all cases. The level of MDC in IEP correlated with that of TARC. AM from IEP patients expressed a significantly higher amount of MDC than that from HV at the levels of protein and mRNA. MDC in BALF from IEP dramatically decreased when patients achieved remission. These findings suggest that MDC, in addition to TARC, might be involved in the pathogenesis of IEP, and AM play a role in the elevation of MDC in IEP.
|
Journal Title |
The journal of medical investigation : JMI
|
ISSN | 13431420
|
NCID | AA11166929
|
Volume | 52
|
Issue | 1-2
|
Start Page | 85
|
End Page | 92
|
Sort Key | 85
|
Published Date | 2005-02
|
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Medical Sciences
University Hospital
|